ロード中...

Myotilin, a New Topotecan Resistant Protein in Ovarian Cancer Cell Lines

Background: Low effectiveness of chemotherapy in ovarian cancer results from development of drug resistance during treatment. Topotecan (TOP) is a chemotherapeutic drug used in second-line chemotherapy of this cancer. Unfortunately, during treatment cancer can develop diverse cellular and tissue spe...

詳細記述

保存先:
書誌詳細
出版年:J Cancer
主要な著者: Sterzyńska, Karolina, Klejewski, Andrzej, Wojtowicz, Karolina, Świerczewska, Monika, Nowicki, Michał, Brązert, Jacek, Januchowski, Radosław
フォーマット: Artigo
言語:Inglês
出版事項: Ivyspring International Publisher 2018
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6277650/
https://ncbi.nlm.nih.gov/pubmed/30519347
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/jca.27342
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!